Trial intelligence / Profile preview

Xalatan vs Travatan Z in Ocular Hypertension or Glaucoma with Dry Eye

NCT00799682Phase 4Completed

Sponsor
Ophthalmic Consultants of Long Island
Start
Oct 2008
Primary completion
Jan 2011
Modality
Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
Countries
1
01

Overview

A Phase 4 trial of latanoprost, travoprost in ocular hypertension, Glaucoma, sponsored by Ophthalmic Consultants of Long Island. Started Oct 2008; status: completed.

02

Drugs

latanoprosttravoprost
03

Conditions

ocular hypertensionGlaucoma

Beyond the preview

Go deeper on NCT00799682.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00799682.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call